Skip to main content
Erschienen in: Child's Nervous System 8/2013

01.08.2013 | Original Paper

Brain stem tumors in children and adolescents: single institutional experience

verfasst von: Magda Garzón, Gemma García-Fructuoso, Antonio Guillén, Mariona Suñol, Jaume Mora, Ofelia Cruz

Erschienen in: Child's Nervous System | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pediatric brain stem tumors (BsT) are a heterogeneous group of diseases. Our aim was to analyze our experience to find out prognostic factors.

Method

A retrospective study with BsT patients was performed. Imaging characteristics, extension of surgery, pathology, and adjuvant therapy were analyzed and correlated with overall survival (OS) and progression-free survival (PFS) as outcome measures.

Result

Since 1980 to 2010, we analyzed 65 BsT patients, 41 of them girls (63 %), median age of 8 years (range 13.9 months to 17.6 years). Twenty-two patients (33.8 %) had diffuse intrinsic pontine gliomas (DIPG) and 43 (66.2 %) presented with focal BsT. Histology was available in 42 patients; the most frequent is low-grade glioma in 24/42 patients (57 %). DIPG’s histology (obtained usually at necropsy) confirmed five high-grade gliomas. After median follow-up of 49.3 months (0.5–175 months), 20/22 DIPG patients have died (90.9 %), while 27/43 with focal tumors were alive (62.8 %). Variables related to outcome were histology (better for low-grade glioma (LGG) OS p < 0.001), surgery (better if operated OS p < 0.001), and adjuvant therapy (worse if given, PFS p = 0.001, OS p = 0.024). The outcome for DIPG was dismal, median OS/EFS of 14.2/9.4 months, significantly worse than focal BsT (p = 0.000), while OS/EFS was 122.8/87.2 months for focal intrinsic, 88.2/47.1 months for exophytic, and 124.4/54 months for cervico–medullary tumors: no differences were found among them, except the histology (OS p < 0.001 for low-grade vs high-grade tumors).

Conclusion

BsT in children comprised two different groups: diffuse (DIPG) and focal gliomas. The DIPGs continue having a dismal prognosis, needing new approaches, while focal tumors including LGG have better prognosis.
Literatur
1.
Zurück zum Zitat Albright AL, Price RA, Guthkelch AN (1983) Brain stem gliomas of children. A clinicopathological study. Cancer 52:2313–2319PubMedCrossRef Albright AL, Price RA, Guthkelch AN (1983) Brain stem gliomas of children. A clinicopathological study. Cancer 52:2313–2319PubMedCrossRef
2.
Zurück zum Zitat Alvisi C, Cerisoli M, Maccheroni ME (1985) Long-term results of surgically treated brainstem gliomas. Acta Neurochir 76:12–17PubMedCrossRef Alvisi C, Cerisoli M, Maccheroni ME (1985) Long-term results of surgically treated brainstem gliomas. Acta Neurochir 76:12–17PubMedCrossRef
3.
Zurück zum Zitat Barkovich AJ, Krischer J, Kun LE et al (1990) Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 16:73–83PubMedCrossRef Barkovich AJ, Krischer J, Kun LE et al (1990) Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 16:73–83PubMedCrossRef
4.
Zurück zum Zitat Behnke J, Christen HJ, Bruck W, Markakis E (1997) Intra-axial endophytic tumors in the pons and/ or medulla oblongata. I. Symptoms, neuroradiological findings, and histopathology in 30 children. Childs Nerv Syst 13:122–134PubMedCrossRef Behnke J, Christen HJ, Bruck W, Markakis E (1997) Intra-axial endophytic tumors in the pons and/ or medulla oblongata. I. Symptoms, neuroradiological findings, and histopathology in 30 children. Childs Nerv Syst 13:122–134PubMedCrossRef
5.
Zurück zum Zitat Bowers DC, Georgiades C, Aronson LJ et al (2000) Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg 32:24–29PubMedCrossRef Bowers DC, Georgiades C, Aronson LJ et al (2000) Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg 32:24–29PubMedCrossRef
6.
Zurück zum Zitat Choux M, Lena G, Do L (2000) Brainstem tumors. In: Choux M, Di Rocco C, Hockley A (eds) Pediatric neurosurgery. Churchill Livingstone, New York, pp 471–491 Choux M, Lena G, Do L (2000) Brainstem tumors. In: Choux M, Di Rocco C, Hockley A (eds) Pediatric neurosurgery. Churchill Livingstone, New York, pp 471–491
7.
Zurück zum Zitat Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24:1266–1272PubMedCrossRef Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24:1266–1272PubMedCrossRef
8.
Zurück zum Zitat Eipstein F, McCleary EL (1986) Intrinsic brain-stem tumors in childhood: surgical indications. J Neurooncol 6:309–317 Eipstein F, McCleary EL (1986) Intrinsic brain-stem tumors in childhood: surgical indications. J Neurooncol 6:309–317
9.
Zurück zum Zitat Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ (1996) Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 24:9–23PubMedCrossRef Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ (1996) Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 24:9–23PubMedCrossRef
10.
Zurück zum Zitat Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI (2009) Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr 3:259–269PubMedCrossRef Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI (2009) Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr 3:259–269PubMedCrossRef
11.
Zurück zum Zitat Fried I, Hawkins C, Scheinemann K et al (2012) Favorable outcome with conservative treatment for children with low grade brainstem tumors. Pediatr Blood Cancer 58:556–560PubMedCrossRef Fried I, Hawkins C, Scheinemann K et al (2012) Favorable outcome with conservative treatment for children with low grade brainstem tumors. Pediatr Blood Cancer 58:556–560PubMedCrossRef
12.
Zurück zum Zitat Hoffman HJ, Becker L, Craven MA (1980) A clinically and pathologically distinct group of benign brain stem gliomas. Neurosurgery 7:243–248PubMedCrossRef Hoffman HJ, Becker L, Craven MA (1980) A clinically and pathologically distinct group of benign brain stem gliomas. Neurosurgery 7:243–248PubMedCrossRef
13.
Zurück zum Zitat Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A, Sarin R, Kurkure P (2010) Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 77:113–118PubMedCrossRef Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A, Sarin R, Kurkure P (2010) Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 77:113–118PubMedCrossRef
14.
Zurück zum Zitat Jallo G, Biser-Rohrbaugh A, Freed D (2004) Brainstem gliomas. Childs NervSyst 20:143–153CrossRef Jallo G, Biser-Rohrbaugh A, Freed D (2004) Brainstem gliomas. Childs NervSyst 20:143–153CrossRef
15.
Zurück zum Zitat Jallo G, Kothbauer K, Epstein F (2000) Surgical management of cervicomedullary and dorsally exophytic brain stem tumors. Oper Tech Neurosurg 3:131–136CrossRef Jallo G, Kothbauer K, Epstein F (2000) Surgical management of cervicomedullary and dorsally exophytic brain stem tumors. Oper Tech Neurosurg 3:131–136CrossRef
16.
Zurück zum Zitat Jallo GI, Freed MS, Roonprapunt C, Epstein F (2003) Current management of brainstem gliomas. Ann Neurosurg 3:1–17 Jallo GI, Freed MS, Roonprapunt C, Epstein F (2003) Current management of brainstem gliomas. Ann Neurosurg 3:1–17
17.
Zurück zum Zitat Milstein JM, Geyer JR, Berger MS, Bleyer WA (1989) Favorable prognosis for brainstem gliomas in neurofibromatosis. J Neurooncol 7:367–371PubMedCrossRef Milstein JM, Geyer JR, Berger MS, Bleyer WA (1989) Favorable prognosis for brainstem gliomas in neurofibromatosis. J Neurooncol 7:367–371PubMedCrossRef
18.
Zurück zum Zitat Mora J, Cruz O, Gala S, Navarro R (2007) Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin. Neuro Oncol 9(1):39–46PubMedCrossRef Mora J, Cruz O, Gala S, Navarro R (2007) Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin. Neuro Oncol 9(1):39–46PubMedCrossRef
19.
Zurück zum Zitat Peris-Bonet R, Felipe GS, Pardo RE et al. (2011) [Cancer in Infancy: 30th years of statistics 1980–2010. National Registry of Infancy tumors (RNTI-SEHOP)]. Valencia, Universitat de València (Prelimiar Edition in CD-ROM). (Spanish) Peris-Bonet R, Felipe GS, Pardo RE et al. (2011) [Cancer in Infancy: 30th years of statistics 1980–2010. National Registry of Infancy tumors (RNTI-SEHOP)]. Valencia, Universitat de València (Prelimiar Edition in CD-ROM). (Spanish)
20.
Zurück zum Zitat Pierre-Kahn A, Hirsch JF, Vinchon M et al (1993) Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases. J Neurosurg 79:845–852PubMedCrossRef Pierre-Kahn A, Hirsch JF, Vinchon M et al (1993) Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases. J Neurosurg 79:845–852PubMedCrossRef
21.
Zurück zum Zitat Pollack IF, Hoffman HJ, Humphreys RP, Becker L (1993) The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 78:859–863PubMedCrossRef Pollack IF, Hoffman HJ, Humphreys RP, Becker L (1993) The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 78:859–863PubMedCrossRef
22.
Zurück zum Zitat Pollack IF, Shultz B, Mulvihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46:1652–1660PubMedCrossRef Pollack IF, Shultz B, Mulvihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46:1652–1660PubMedCrossRef
23.
Zurück zum Zitat Ronghe M, Hargrave D, Bartels U, Tabori U et al (2000) Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem. Ped Blood & Cancer 55:471–477CrossRef Ronghe M, Hargrave D, Bartels U, Tabori U et al (2000) Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem. Ped Blood & Cancer 55:471–477CrossRef
24.
Zurück zum Zitat Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L (2007) Brainstem lesions in neurofibromatosis type 1. Neurosurgery 61:762–766PubMedCrossRef Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L (2007) Brainstem lesions in neurofibromatosis type 1. Neurosurgery 61:762–766PubMedCrossRef
Metadaten
Titel
Brain stem tumors in children and adolescents: single institutional experience
verfasst von
Magda Garzón
Gemma García-Fructuoso
Antonio Guillén
Mariona Suñol
Jaume Mora
Ofelia Cruz
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 8/2013
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-013-2137-1

Weitere Artikel der Ausgabe 8/2013

Child's Nervous System 8/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.